198 related articles for article (PubMed ID: 24266862)
1. SAR studies on trisubstituted benzimidazoles as inhibitors of Mtb FtsZ for the development of novel antitubercular agents.
Awasthi D; Kumar K; Knudson SE; Slayden RA; Ojima I
J Med Chem; 2013 Dec; 56(23):9756-70. PubMed ID: 24266862
[TBL] [Abstract][Full Text] [Related]
2. Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents.
Kumar K; Awasthi D; Lee SY; Zanardi I; Ruzsicska B; Knudson S; Tonge PJ; Slayden RA; Ojima I
J Med Chem; 2011 Jan; 54(1):374-81. PubMed ID: 21126020
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents.
Park B; Awasthi D; Chowdhury SR; Melief EH; Kumar K; Knudson SE; Slayden RA; Ojima I
Bioorg Med Chem; 2014 May; 22(9):2602-12. PubMed ID: 24726304
[TBL] [Abstract][Full Text] [Related]
4. Identification of TB-E12 as a novel FtsZ inhibitor with anti-tuberculosis activity.
Lin Y; Zhang H; Zhu N; Wang X; Han Y; Chen M; Jiang J; Si S
Tuberculosis (Edinb); 2018 May; 110():79-85. PubMed ID: 29779778
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics analysis of the effects of GTP, GDP and benzimidazole derivative on structural dynamics of a cell division protein FtsZ from
Hakeem S; Singh I; Sharma P; Uppal A; Khajuria Y; Verma V; Uversky VN; Chandra R
J Biomol Struct Dyn; 2019 Oct; 37(16):4361-4373. PubMed ID: 30466358
[TBL] [Abstract][Full Text] [Related]
6. FtsZ: a novel target for tuberculosis drug discovery.
Huang Q; Tonge PJ; Slayden RA; Kirikae T; Ojima I
Curr Top Med Chem; 2007; 7(5):527-43. PubMed ID: 17346197
[TBL] [Abstract][Full Text] [Related]
7. Identification of anti-tuberculosis agents that target the cell-division protein FtsZ.
Lin Y; Zhu N; Han Y; Jiang J; Si S
J Antibiot (Tokyo); 2014 Sep; 67(9):671-6. PubMed ID: 24984796
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship studies on 2,5,6-trisubstituted benzimidazoles targeting
Haranahalli K; Tong S; Kim S; Awwa M; Chen L; Knudson SE; Slayden RA; Singleton E; Russo R; Connell N; Ojima I
RSC Med Chem; 2021 Jan; 12(1):78-94. PubMed ID: 34046600
[TBL] [Abstract][Full Text] [Related]
9. Computational studies of the properties and activities of selected trisubstituted benzimidazoles as potential antitubercular drugs inhibiting MTB-FtsZ polymerization.
Akinpelu OI; Lawal MM; Kumalo HM; Mhlongo NN
J Biomol Struct Dyn; 2022 Mar; 40(4):1558-1570. PubMed ID: 33021149
[TBL] [Abstract][Full Text] [Related]
10. Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors.
Mathew B; Srivastava S; Ross LJ; Suling WJ; White EL; Woolhiser LK; Lenaerts AJ; Reynolds RC
Bioorg Med Chem; 2011 Dec; 19(23):7120-8. PubMed ID: 22024272
[TBL] [Abstract][Full Text] [Related]
11. Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents.
Huang Q; Kirikae F; Kirikae T; Pepe A; Amin A; Respicio L; Slayden RA; Tonge PJ; Ojima I
J Med Chem; 2006 Jan; 49(2):463-6. PubMed ID: 16420032
[TBL] [Abstract][Full Text] [Related]
12. Discovery of anti-TB agents that target the cell-division protein FtsZ.
Kumar K; Awasthi D; Berger WT; Tonge PJ; Slayden RA; Ojima I
Future Med Chem; 2010 Aug; 2(8):1305-23. PubMed ID: 21339840
[TBL] [Abstract][Full Text] [Related]
13. An efficient and facile green synthesis of bisindole methanes as potential Mtb FtsZ inhibitors.
Khadkikar P; Goud NS; Mohammed A; Ramamoorthy G; Ananthathatmula R; Doble M; Rizvi A; Banerjee S; Ravi A; Alvala M
Chem Biol Drug Des; 2018 Dec; 92(6):1933-1939. PubMed ID: 30003661
[TBL] [Abstract][Full Text] [Related]
14. Screening and Development of New Inhibitors of FtsZ from M. Tuberculosis.
Mathew B; Hobrath JV; Ross L; Connelly MC; Lofton H; Rajagopalan M; Guy RK; Reynolds RC
PLoS One; 2016; 11(10):e0164100. PubMed ID: 27768711
[TBL] [Abstract][Full Text] [Related]
15. A new 2-carbamoyl pteridine that inhibits mycobacterial FtsZ.
Reynolds RC; Srivastava S; Ross LJ; Suling WJ; White EL
Bioorg Med Chem Lett; 2004 Jun; 14(12):3161-4. PubMed ID: 15149666
[TBL] [Abstract][Full Text] [Related]
16. 2/3D-QSAR, molecular docking and MD simulation studies of FtsZ protein targeting benzimidazoles derivatives.
Ahamad S; Islam A; Ahmad F; Dwivedi N; Hassan MI
Comput Biol Chem; 2019 Feb; 78():398-413. PubMed ID: 30602415
[TBL] [Abstract][Full Text] [Related]
17. A novel quinoline derivative that inhibits mycobacterial FtsZ.
Mathew B; Ross L; Reynolds RC
Tuberculosis (Edinb); 2013 Jul; 93(4):398-400. PubMed ID: 23647650
[TBL] [Abstract][Full Text] [Related]
18. Drug repurposing: Fusidic acid as a potential inhibitor of M. tuberculosis FtsZ polymerization - Insight from DFT calculations, molecular docking and molecular dynamics simulations.
Akinpelu OI; Lawal MM; Kumalo HM; Mhlongo NN
Tuberculosis (Edinb); 2020 Mar; 121():101920. PubMed ID: 32279872
[TBL] [Abstract][Full Text] [Related]
19. Strategic incorporation of fluorine in the drug discovery of new-generation antitubercular agents targeting bacterial cell division protein FtsZ.
Ojima I; Awasthi D; Wei L; Haranahalli K
J Fluor Chem; 2017 Apr; 196():44-56. PubMed ID: 28555087
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
Devi PB; Sridevi JP; Kakan SS; Saxena S; Jeankumar VU; Soni V; Anantaraju HS; Yogeeswari P; Sriram D
Tuberculosis (Edinb); 2015 Dec; 95(6):786-794. PubMed ID: 26299907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
